Evaluation of the haematinic, antioxidant and anti-atherosclerotic potential of Momordica charantia in cholesterol-fed experimental rats

Background: Momordica charantia is popularly used in folk medicine in the management of hyperlipidemia and atherosclerosis. Purpose: To evaluate the anti-atherosclerotic potential of M. charantia as well as its haematinic and antioxidant potential. Methods: Seventy-two experimental rats were randoml...

Full description

Bibliographic Details
Main Authors: Silvanus Olu Innih, Ikechi Gerald Eze, Kingsley Omage
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Toxicology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750022000713
_version_ 1811295710895669248
author Silvanus Olu Innih
Ikechi Gerald Eze
Kingsley Omage
author_facet Silvanus Olu Innih
Ikechi Gerald Eze
Kingsley Omage
author_sort Silvanus Olu Innih
collection DOAJ
description Background: Momordica charantia is popularly used in folk medicine in the management of hyperlipidemia and atherosclerosis. Purpose: To evaluate the anti-atherosclerotic potential of M. charantia as well as its haematinic and antioxidant potential. Methods: Seventy-two experimental rats were randomly assigned into 9 groups (I-IX) of 8 rats each. Group I (control), was given 1 ml distilled water; II received 250 mg/kg. M. charantia; III received 500 mg/kg M. charantia; IV was administered 100 mg/kg of Atorvastatin only; V was administered 30 mg/kg of cholesterol dissolved in coconut oil; VI was administered with 250 mg/kg of M. charantia plus 30 mg/kg of cholesterol. VII was treated with 500 mg/kg of M. charantia plus 30 mg/kg of cholesterol solution; VIII was administered 30 mg/kg cholesterol solution plus Atorvastatin at a dose of 100 mg/kg; IX was administered 1 ml of coconut oil only. After 60 days of administration, blood and aorta samples were obtained from the rats. The samples were subjected to biochemical, haematological and histological analysis using standard methods. Results: Glutathione peroxidase (GPx), Malondialdehyde (MDA) and Catalase (CAT) activities were significantly higher in the treated groups as compared to the control groups. There were significant increases in the monocyte counts of the groups given low dose (250 mg/kg) of the extract (LDMC), high dose (500 mg/kg) of the extract (HDMC), as well as atorvastatin. The mean corpuscular volume (MCV) and mean corpuscular haemoglobin (MCH) of the test groups administered were significantly higher than that of the control group. However, only the group administered with cholesterol plus HDMC showed significantly lower mean corpuscular haemoglobin concentration (MCHC) than that of the control group. Histological sections of the aorta show degeneration of the internal elastic lamina in the group fed with the diet only as well as vascular ulceration and stenosis in the aorta and heavy perivascular infiltrates of inflammatory cells. These alterations were however not visible in the groups administered with the extracts, as well as atorvastatin Conclusion: Our findings show the possible anti-atherosclerotic potential of the extract, which could be compared to that of the standard drug (atorvastatin).
first_indexed 2024-04-13T05:37:32Z
format Article
id doaj.art-89e76f478b5c4297bd504f70c0875b0b
institution Directory Open Access Journal
issn 2214-7500
language English
last_indexed 2024-04-13T05:37:32Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Toxicology Reports
spelling doaj.art-89e76f478b5c4297bd504f70c0875b0b2022-12-22T03:00:14ZengElsevierToxicology Reports2214-75002022-01-019611618Evaluation of the haematinic, antioxidant and anti-atherosclerotic potential of Momordica charantia in cholesterol-fed experimental ratsSilvanus Olu Innih0Ikechi Gerald Eze1Kingsley Omage2Department of Anatomy, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, NigeriaDepartment of Anatomy, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, NigeriaDepartment of Biochemistry, College of Basic Medical Sciences, Igbinedion University, Okada, Edo State, Nigeria; Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, University Hospital Tübingen, Germany; Corresponding author at: Department of Biochemistry, College of Basic Medical Sciences, Igbinedion University, Okada, Edo State, Nigeria.Background: Momordica charantia is popularly used in folk medicine in the management of hyperlipidemia and atherosclerosis. Purpose: To evaluate the anti-atherosclerotic potential of M. charantia as well as its haematinic and antioxidant potential. Methods: Seventy-two experimental rats were randomly assigned into 9 groups (I-IX) of 8 rats each. Group I (control), was given 1 ml distilled water; II received 250 mg/kg. M. charantia; III received 500 mg/kg M. charantia; IV was administered 100 mg/kg of Atorvastatin only; V was administered 30 mg/kg of cholesterol dissolved in coconut oil; VI was administered with 250 mg/kg of M. charantia plus 30 mg/kg of cholesterol. VII was treated with 500 mg/kg of M. charantia plus 30 mg/kg of cholesterol solution; VIII was administered 30 mg/kg cholesterol solution plus Atorvastatin at a dose of 100 mg/kg; IX was administered 1 ml of coconut oil only. After 60 days of administration, blood and aorta samples were obtained from the rats. The samples were subjected to biochemical, haematological and histological analysis using standard methods. Results: Glutathione peroxidase (GPx), Malondialdehyde (MDA) and Catalase (CAT) activities were significantly higher in the treated groups as compared to the control groups. There were significant increases in the monocyte counts of the groups given low dose (250 mg/kg) of the extract (LDMC), high dose (500 mg/kg) of the extract (HDMC), as well as atorvastatin. The mean corpuscular volume (MCV) and mean corpuscular haemoglobin (MCH) of the test groups administered were significantly higher than that of the control group. However, only the group administered with cholesterol plus HDMC showed significantly lower mean corpuscular haemoglobin concentration (MCHC) than that of the control group. Histological sections of the aorta show degeneration of the internal elastic lamina in the group fed with the diet only as well as vascular ulceration and stenosis in the aorta and heavy perivascular infiltrates of inflammatory cells. These alterations were however not visible in the groups administered with the extracts, as well as atorvastatin Conclusion: Our findings show the possible anti-atherosclerotic potential of the extract, which could be compared to that of the standard drug (atorvastatin).http://www.sciencedirect.com/science/article/pii/S2214750022000713Momordica charantiaAtherosclerosisOxidative stressDifferential blood countHaematocritAtorvastatin
spellingShingle Silvanus Olu Innih
Ikechi Gerald Eze
Kingsley Omage
Evaluation of the haematinic, antioxidant and anti-atherosclerotic potential of Momordica charantia in cholesterol-fed experimental rats
Toxicology Reports
Momordica charantia
Atherosclerosis
Oxidative stress
Differential blood count
Haematocrit
Atorvastatin
title Evaluation of the haematinic, antioxidant and anti-atherosclerotic potential of Momordica charantia in cholesterol-fed experimental rats
title_full Evaluation of the haematinic, antioxidant and anti-atherosclerotic potential of Momordica charantia in cholesterol-fed experimental rats
title_fullStr Evaluation of the haematinic, antioxidant and anti-atherosclerotic potential of Momordica charantia in cholesterol-fed experimental rats
title_full_unstemmed Evaluation of the haematinic, antioxidant and anti-atherosclerotic potential of Momordica charantia in cholesterol-fed experimental rats
title_short Evaluation of the haematinic, antioxidant and anti-atherosclerotic potential of Momordica charantia in cholesterol-fed experimental rats
title_sort evaluation of the haematinic antioxidant and anti atherosclerotic potential of momordica charantia in cholesterol fed experimental rats
topic Momordica charantia
Atherosclerosis
Oxidative stress
Differential blood count
Haematocrit
Atorvastatin
url http://www.sciencedirect.com/science/article/pii/S2214750022000713
work_keys_str_mv AT silvanusoluinnih evaluationofthehaematinicantioxidantandantiatheroscleroticpotentialofmomordicacharantiaincholesterolfedexperimentalrats
AT ikechigeraldeze evaluationofthehaematinicantioxidantandantiatheroscleroticpotentialofmomordicacharantiaincholesterolfedexperimentalrats
AT kingsleyomage evaluationofthehaematinicantioxidantandantiatheroscleroticpotentialofmomordicacharantiaincholesterolfedexperimentalrats